1.56
0.00 (0.0%)
0.00 (0.0%)
Upgrade to Real-Time
Premarket
Best deals to access real time data! |
|
CHART Trader
Monthly Subscription
for only
|
|
Canadian Level 1 + USA
Monthly Subscription
for only
|
|
Small Cap Basic
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Matinas Biopharma Holdings Inc | MTNB | AMEX | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded  |
|
|---|---|---|---|---|
| 0.00 | 0.0% | 1.56 | 04:11:42 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 1.56 |
| Trades | Volume | Avg Volume | 52 Week Range |
|---|---|---|---|
| 6 | 164 | 6,580,147 | 0.49 - 2.22 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 04:12:18 | 1 | $ 1.61 | USD |
Matinas Biopharma Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| $ 311.44M | 199.64M | 191.87M | $ 89.81k | $ - | -0.14 | -12.00 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ - | 0.00% | - | - |
Matinas Biopharma News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical MTNB Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 1.67 | 1.67 | 1.52 | 1.60 | 2,517,732 | -0.11 | -6.59% |
| 1 Month | 0.9897 | 2.22 | 0.852 | 1.51 | 9,130,734 | 0.5703 | 57.62% |
| 3 Months | 0.801 | 2.22 | 0.73 | 1.33 | 4,746,755 | 0.759 | 94.76% |
| 6 Months | 0.9349 | 2.22 | 0.66 | 1.15 | 3,266,697 | 0.6251 | 66.86% |
| 1 Year | 1.45 | 2.22 | 0.49 | 1.05 | 2,625,793 | 0.11 | 7.59% |
| 3 Years | 1.16 | 2.49 | 0.3237 | 1.06 | 1,700,881 | 0.40 | 34.48% |
| 5 Years | 3.99 | 4.35 | 0.3237 | 1.13 | 1,389,374 | -2.43 | -60.9% |
Matinas Biopharma Description
| Matinas BioPharma Holdings Inc is a clinical-stage biopharmaceutical company focused on the discovery and development of product candidates derived from its lipid-crystal nano-particle, or cochleate, delivery technology platform. The firm's pipeline includes MAT2203, MAT2501 and others. |
